Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cornet

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|June 5, 1990
Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. Possible involvement in late steps of the mitogenic cascadeM Lopez-Barahona, P L Kaplan, M E Cornet, et al.
Allergy|May 16, 2025
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory DiseaseH B E Elzinga, J J Otten, M E Cornet, et al.
Molecular and Cellular Biology|January 1, 1992
Phospholipase C-mediated hydrolysis of phosphatidylcholine is a target of transforming growth factor beta 1 inhibitory signalsM T Diaz-Meco, I Dominguez, L Sanz, et al.
The Journal of Biological Chemistry|January 15, 1991
Mechanism of inhibition of adenylate cyclase by phospholipase C-catalyzed hydrolysis of phosphatidylcholine. Involvement of a pertussis toxin-sensitive G protein and protein kinase CI Diaz-Laviada, P Larrodera, J L Nieto, et al.
The EMBO Journal|November 1, 1991
Role of GTPase activating protein in mitogenic signalling through phosphatidylcholine-hydrolysing phospholipase CI Dominguez, M S Marshall, J B Gibbs, et al.
Rhinology|March 13, 2024
Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polypsR van der Lans, J J Otten, G F J P M Adriaensen, et al.
Cephalalgia : an International Journal of Headache|July 27, 2001
Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre studyP Martínez-Martín, E Raffaelli, F Titus, et al.
Rhinology|November 24, 2023
Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polypsP Kemp, R J L van der Lans, J J Otten, et al.
Rhinology|March 27, 2026
Revision endoscopic sinus surgery is rarely needed in dupilumab-treated chronic rhinosinusitis with nasal polypsP Kemp, J J Otten, H B E Elzinga, et al.
Rhinology|February 21, 2025
Remission in chronic rhinosinusitis with nasal polyps (CRSwNP)P W Hellings, E De Corso, V Backer, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 5, 1990
Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. Possible involvement in late steps of the mitogenic cascadeM Lopez-Barahona, P L Kaplan, M E Cornet, et al.
Allergy|May 16, 2025
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory DiseaseH B E Elzinga, J J Otten, M E Cornet, et al.
Molecular and Cellular Biology|January 1, 1992
Phospholipase C-mediated hydrolysis of phosphatidylcholine is a target of transforming growth factor beta 1 inhibitory signalsM T Diaz-Meco, I Dominguez, L Sanz, et al.
The Journal of Biological Chemistry|January 15, 1991
Mechanism of inhibition of adenylate cyclase by phospholipase C-catalyzed hydrolysis of phosphatidylcholine. Involvement of a pertussis toxin-sensitive G protein and protein kinase CI Diaz-Laviada, P Larrodera, J L Nieto, et al.
The EMBO Journal|November 1, 1991
Role of GTPase activating protein in mitogenic signalling through phosphatidylcholine-hydrolysing phospholipase CI Dominguez, M S Marshall, J B Gibbs, et al.
Rhinology|March 13, 2024
Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polypsR van der Lans, J J Otten, G F J P M Adriaensen, et al.
Cephalalgia : an International Journal of Headache|July 27, 2001
Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre studyP Martínez-Martín, E Raffaelli, F Titus, et al.
Rhinology|November 24, 2023
Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polypsP Kemp, R J L van der Lans, J J Otten, et al.
Rhinology|March 27, 2026
Revision endoscopic sinus surgery is rarely needed in dupilumab-treated chronic rhinosinusitis with nasal polypsP Kemp, J J Otten, H B E Elzinga, et al.
Rhinology|February 21, 2025
Remission in chronic rhinosinusitis with nasal polyps (CRSwNP)P W Hellings, E De Corso, V Backer, et al.
Pageof 3